Tyrosine kinase inhibitors
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Tyrosine kinase inhibitors, covering 2022-07-01 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults [Phase 3]